Your browser doesn't support javascript.
loading
Targeted delivery of antisense oligonucleotides to pancreatic ß-cells.
Ämmälä, C; Drury, W J; Knerr, L; Ahlstedt, I; Stillemark-Billton, P; Wennberg-Huldt, C; Andersson, E-M; Valeur, E; Jansson-Löfmark, R; Janzén, D; Sundström, L; Meuller, J; Claesson, J; Andersson, P; Johansson, C; Lee, R G; Prakash, T P; Seth, P P; Monia, B P; Andersson, S.
Afiliación
  • Ämmälä C; Cardiovascular Renal and Metabolic Diseases, IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden.
  • Drury WJ; Cardiovascular Renal and Metabolic Diseases, IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden.
  • Knerr L; Cardiovascular Renal and Metabolic Diseases, IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden.
  • Ahlstedt I; Cardiovascular Renal and Metabolic Diseases, IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden.
  • Stillemark-Billton P; Cardiovascular Renal and Metabolic Diseases, IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden.
  • Wennberg-Huldt C; Cardiovascular Renal and Metabolic Diseases, IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden.
  • Andersson EM; Cardiovascular Renal and Metabolic Diseases, IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden.
  • Valeur E; Cardiovascular Renal and Metabolic Diseases, IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden.
  • Jansson-Löfmark R; Cardiovascular Renal and Metabolic Diseases, IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden.
  • Janzén D; Cardiovascular Renal and Metabolic Diseases, IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden.
  • Sundström L; Discovery Sciences, IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden.
  • Meuller J; Discovery Sciences, IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden.
  • Claesson J; Discovery Sciences, IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden.
  • Andersson P; Drug Safety and Metabolism, IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden.
  • Johansson C; Drug Safety and Metabolism, IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden.
  • Lee RG; Ionis Pharmaceuticals, 2855 Gazelle Court, Carlsbad, CA 92010, USA.
  • Prakash TP; Ionis Pharmaceuticals, 2855 Gazelle Court, Carlsbad, CA 92010, USA.
  • Seth PP; Ionis Pharmaceuticals, 2855 Gazelle Court, Carlsbad, CA 92010, USA.
  • Monia BP; Ionis Pharmaceuticals, 2855 Gazelle Court, Carlsbad, CA 92010, USA.
  • Andersson S; Cardiovascular Renal and Metabolic Diseases, IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden.
Sci Adv ; 4(10): eaat3386, 2018 10.
Article en En | MEDLINE | ID: mdl-30345352
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Oligonucleótidos Antisentido / Sistemas de Liberación de Medicamentos / Células Secretoras de Insulina / Receptor del Péptido 1 Similar al Glucagón Límite: Animals / Humans Idioma: En Revista: Sci Adv Año: 2018 Tipo del documento: Article País de afiliación: Suecia Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Oligonucleótidos Antisentido / Sistemas de Liberación de Medicamentos / Células Secretoras de Insulina / Receptor del Péptido 1 Similar al Glucagón Límite: Animals / Humans Idioma: En Revista: Sci Adv Año: 2018 Tipo del documento: Article País de afiliación: Suecia Pais de publicación: Estados Unidos